Our success is built on our clients’ success. We have a long and distinguished history of supporting our clients wherever they do business, from major financial centers to emerging and growth markets. We represent many of the world’s leading corporations and major financial institutions, as well as emerging growth companies, governments and state-owned enterprises, often working on ground-breaking, precedent-setting matters. With a deep understanding of our clients' businesses and the industries they operate in, our work is driven by their need for outstanding legal and commercial advice.
Associate Timothy Slattery (Antitrust-Washington, DC) has contributed to the Pharmaceutical Industry Antitrust Handbook (2nd Ed.) published by the American Bar Association
Associate Timothy Slattery (Antitrust-Washington, DC) has
contributed to the Pharmaceutical Industry Antitrust
Handbook (2nd Ed.) published by the American Bar Association.
Tim was Editor and Contributing Author to Chapter II
"Regulatory and Enforcement Framework" of the book.
The chapter covers subjects such as FDA drug approval
requirements, The Hatch-Waxman Act, government antitrust
enforcement, private suits and class actions relating to reverse
payment settlements, and government price regulation.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
